Larimar Therapeutics, Inc. (LRMR)
2.28
+0.01
(+0.44%)
USD |
NASDAQ |
Oct 23, 10:26
Larimar Therapeutics Price : 2.28 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 22, 2026 | 2.40 | 2.509 | 2.235 | 2.27 | 1.764M |
| Oct 21, 2026 | 2.40 | 2.54 | 2.39 | 2.42 | 1.513M |
| Oct 20, 2026 | 2.12 | 2.49 | 2.10 | 2.44 | 1.811M |
| Oct 19, 2026 | 1.99 | 2.175 | 1.96 | 2.12 | 1.231M |
| Oct 16, 2026 | 2.05 | 2.07 | 1.915 | 1.985 | 1.692M |
| Oct 15, 2026 | 2.09 | 2.115 | 1.95 | 1.99 | 6.180M |
| Oct 14, 2026 | 2.15 | 2.22 | 2.06 | 2.09 | 2.257M |
| Oct 13, 2026 | 2.53 | 2.53 | 2.13 | 2.16 | 2.573M |
| Oct 12, 2026 | 2.66 | 2.69 | 2.53 | 2.53 | 952184.0 |
| Oct 09, 2026 | 2.68 | 2.74 | 2.62 | 2.67 | 868878.0 |
| Oct 08, 2026 | 2.72 | 2.74 | 2.61 | 2.70 | 1.191M |
| Oct 07, 2026 | 2.77 | 2.835 | 2.72 | 2.75 | 717993.0 |
| Oct 06, 2026 | 2.88 | 2.90 | 2.74 | 2.78 | 829229.0 |
| Oct 05, 2026 | 2.96 | 3.04 | 2.775 | 2.86 | 886144.0 |
| Oct 02, 2026 | 3.11 | 3.11 | 2.92 | 2.96 | 835020.0 |
| Oct 01, 2026 | 3.20 | 3.20 | 3.04 | 3.06 | 858311.0 |
| Sep 30, 2026 | 3.13 | 3.225 | 3.075 | 3.195 | 1.497M |
| Sep 29, 2026 | 3.13 | 3.20 | 3.115 | 3.14 | 1.042M |
| Sep 28, 2026 | 3.04 | 3.231 | 3.03 | 3.17 | 1.673M |
| Sep 25, 2026 | 3.32 | 3.34 | 3.02 | 3.075 | 3.047M |
| Sep 24, 2026 | 3.85 | 3.86 | 3.305 | 3.32 | 3.633M |
| Sep 23, 2026 | 3.82 | 3.90 | 3.71 | 3.865 | 2.719M |
| Sep 22, 2026 | 3.91 | 3.965 | 3.815 | 3.82 | 702938.0 |
| Sep 21, 2026 | 3.84 | 3.885 | 3.78 | 3.83 | 579330.0 |
| Sep 18, 2026 | 3.81 | 3.88 | 3.75 | 3.79 | 1.641M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.77 |
| Alnylam Pharmaceuticals, Inc. | 223.79 |
| Anika Therapeutics, Inc. | 21.09 |
| Savara, Inc. | 4.22 |
| Vericel Corp. | 42.57 |
Price Related Metrics
| PEG Ratio | -0.0426 |
| Price to Book Value | 1.868 |
| Earnings Yield | -86.97% |
| Market Cap | 237.99M |
| PEGY Ratio | -0.0426 |